NCT04532554View on ClinicalTrials.gov

Growth Hormone in Obese Cases With Covid-19

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 26, 2020

Primary Completion Date

December 10, 2020

Study Completion Date

December 20, 2020

Conditions
Covid19
Interventions
DRUG

Growth Hormone

Recombinant growth hormone will be used

DRUG

Placebo

Saline injection with the same amount

Trial Locations (1)

11433

Asalam, Maadi

Sponsors

Lead Sponsor

ClinAmygate
All Listed Sponsors
lead

ClinAmygate

OTHER

NCT04532554 - Growth Hormone in Obese Cases With Covid-19 | Biotech Hunter | Biotech Hunter